GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 783 filers reported holding GLAXOSMITHKLINE PLC in Q2 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,565,000 | -16.2% | 94,708 | -9.2% | 0.37% | -16.4% |
| Q2 2020 | $4,255,000 | +7.9% | 104,303 | +0.2% | 0.44% | -6.1% |
| Q1 2020 | $3,945,000 | -21.3% | 104,113 | -2.4% | 0.47% | +0.9% |
| Q4 2019 | $5,015,000 | +9.8% | 106,719 | -0.3% | 0.47% | +1.3% |
| Q3 2019 | $4,567,000 | +5.9% | 107,006 | -0.7% | 0.46% | +6.7% |
| Q2 2019 | $4,311,000 | -2.7% | 107,729 | +1.6% | 0.44% | -9.4% |
| Q1 2019 | $4,431,000 | +21.1% | 106,019 | +10.7% | 0.48% | +7.9% |
| Q4 2018 | $3,658,000 | -9.2% | 95,739 | -4.5% | 0.44% | +7.0% |
| Q3 2018 | $4,029,000 | -2.0% | 100,295 | -1.7% | 0.42% | -9.4% |
| Q2 2018 | $4,113,000 | +9.0% | 102,023 | +5.6% | 0.46% | +8.0% |
| Q1 2018 | $3,774,000 | +10.7% | 96,593 | +0.5% | 0.42% | +13.6% |
| Q4 2017 | $3,409,000 | -15.9% | 96,101 | -3.7% | 0.37% | -20.3% |
| Q3 2017 | $4,052,000 | -1.9% | 99,803 | +4.2% | 0.47% | -11.7% |
| Q2 2017 | $4,129,000 | +4.1% | 95,759 | +1.7% | 0.53% | +3.1% |
| Q1 2017 | $3,968,000 | +27.7% | 94,119 | +16.7% | 0.52% | +22.3% |
| Q4 2016 | $3,107,000 | -2.6% | 80,669 | +9.1% | 0.42% | -10.6% |
| Q3 2016 | $3,190,000 | +4.6% | 73,954 | +5.0% | 0.47% | 0.0% |
| Q2 2016 | $3,051,000 | +22.1% | 70,404 | +14.3% | 0.47% | +13.8% |
| Q1 2016 | $2,498,000 | +27.7% | 61,599 | +27.1% | 0.41% | +20.3% |
| Q4 2015 | $1,956,000 | +2.8% | 48,474 | -2.1% | 0.34% | -9.5% |
| Q3 2015 | $1,903,000 | -7.6% | 49,489 | +0.1% | 0.38% | -3.8% |
| Q2 2015 | $2,059,000 | -14.9% | 49,439 | -5.7% | 0.40% | -6.2% |
| Q1 2015 | $2,419,000 | +51.9% | 52,414 | +40.7% | 0.42% | +45.7% |
| Q4 2014 | $1,593,000 | +13.5% | 37,264 | +22.1% | 0.29% | +10.3% |
| Q3 2014 | $1,403,000 | -13.7% | 30,514 | +0.4% | 0.26% | -13.8% |
| Q2 2014 | $1,625,000 | +3.6% | 30,389 | +3.6% | 0.30% | -1.9% |
| Q1 2014 | $1,568,000 | +1.0% | 29,339 | +0.9% | 0.31% | +9.2% |
| Q4 2013 | $1,552,000 | +9.5% | 29,067 | +2.9% | 0.28% | -2.7% |
| Q3 2013 | $1,417,000 | +5.0% | 28,238 | +4.5% | 0.29% | +0.3% |
| Q2 2013 | $1,350,000 | – | 27,010 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |